XORTX Therapeutics Inc. is a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease. The company is actively involved in creating ...

XORTX Therapeutics (XRTX) announces the launch of a new late stage program to treat gout. The new drug development program – XRx-026 – will ...

XORTX to focus on late stage allopurinol intolerant gout program; discussion with FDA planned for first half 2025 regarding ...

This lets uric acid accumulate, crystallize, and settle in the joints. Managing gout is possible with medications, lifestyle changes, and a gout-friendly diet. This article reviews the best diets ...

Objective Macrophage activation by monosodium urate (MSU) and calcium pyrophosphate (CPP) crystals mediates an interleukin (IL)-1β-dependent inflammation during gout and pseudo-gout flare, ...

Colchicine, a medication commonly used for gout and other inflammatory conditions, has shown promise in managing inflammation. However, it is not currently approved for treating osteoarthritis ...

Experts debate the merits of using allopurinol as the first-line therapy for all gout patients versus tailoring treatment to the individual's hyperuricemia mechanism. A recent debate at the annual ...

Stamp emphasized the importance of drug availability and noted that allopurinol is also the only medication for gout that is on the World Health Organization list of essential medications.

Dec 16 (Reuters) - Merck (MRK.N), opens new tab said on Monday it has discontinued the development of two experimental cancer drugs after their failure in several trials. The pharmaceutical giant ...

Gout is a painful condition affecting the joints. The study by SingHealth Polyclinics also finds patients were not receiving the right amount of allopurinol, a drug used to treat gout - if they ...

Watch Australian teenage sensation Gout Gout enter the record books by becoming the fastest 16-year-old in history over 200m with a time of 20.04 seconds. READ MORE: Sixteen-year-old breaks 200m ...